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Impaired Fitness and Transmission of Macrolide-Resistant Campylobacter
jejuni in Its Natural Host
Abstract
Campylobacter jejuni is a major zoonotic pathogen transmitted to humans via the food chain and is prevalent
in chickens, a natural reservoir for this pathogenic organism. Due to the importance of macrolide antibiotics
in clinical therapy of human campylobacteriosis, development of macrolide resistance in Campylobacter has
become a concern for public health. To facilitate the control of macrolide-resistant Campylobacter, it is
necessary to understand if macrolide resistance affects the fitness and transmission of Campylobacter in its
natural host. In this study we conducted pairwise competitions and comingling experiments in chickens using
clonally related and isogenic C. jejuni strains, which are either susceptible or resistant to erythromycin (Ery).
In every competition pair, Ery-resistant (Eryr) Campylobacter was consistently outcompeted by the Ery-
susceptible (Erys) strain. In the comingling experiments, Eryr Campylobacter failed to transmit to chickens
precolonized by Erys Campylobacter, while isogenic Erys Campylobacter was able to transmit to and establish
dominance in chickens precolonized by Eryr Campylobacter. The fitness disadvantage was linked to the
resistance-conferring mutations in the 23S rRNA. These findings clearly indicate that acquisition of macrolide
resistance impairs the fitness and transmission of Campylobacter in chickens, suggesting that the prevalence of
macrolide-resistant C. jejuni will likely decrease in the absence of antibiotic selection pressure.
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Campylobacter jejuni is a major zoonotic pathogen transmitted to humans via the food chain and is prevalent in chickens, a nat-
ural reservoir for this pathogenic organism. Due to the importance of macrolide antibiotics in clinical therapy of human campy-
lobacteriosis, development of macrolide resistance in Campylobacter has become a concern for public health. To facilitate the
control of macrolide-resistant Campylobacter, it is necessary to understand if macrolide resistance affects the fitness and trans-
mission of Campylobacter in its natural host. In this study we conducted pairwise competitions and comingling experiments in
chickens using clonally related and isogenic C. jejuni strains, which are either susceptible or resistant to erythromycin (Ery).
In every competition pair, Ery-resistant (Eryr) Campylobacterwas consistently outcompeted by the Ery-susceptible (Erys) strain.
In the comingling experiments, Eryr Campylobacter failed to transmit to chickens precolonized by Erys Campylobacter, while
isogenic Erys Campylobacterwas able to transmit to and establish dominance in chickens precolonized by Eryr Campylobacter.
The fitness disadvantage was linked to the resistance-conferring mutations in the 23S rRNA. These findings clearly indicate that
acquisition of macrolide resistance impairs the fitness and transmission of Campylobacter in chickens, suggesting that the preva-
lence of macrolide-resistant C. jejuniwill likely decrease in the absence of antibiotic selection pressure.
Campylobacter jejuni has been recognized as one of the mostcommon causes of human enterocolitis worldwide (2). This
organism is transmitted to humans via contaminated foods of
animal origin, especially undercooked poultry meat and unpas-
teurizedmilk/dairy products (2, 4). Although antibiotic treatment
may not be necessary for most food-borne campylobacteriosis
cases, antimicrobial therapy is warranted in patients with severe or
prolonged infections (2, 12). Generally, erythromycin (Ery) and
ciprofloxacin are considered the main antimicrobials for treating
human campylobacteriosis (2, 12, 17). However, during the past
decades Campylobacter has become increasingly resistant to clin-
ically important antimicrobial agents, compromising the effec-
tiveness of clinical therapy (17). Since antimicrobial-resistant
Campylobacter can be transmitted from food animals to humans
through the food chain, the rising resistance to antibiotics among
Campylobacter isolates of animal origin is a concern for public
health.
Ery, a 14-membered ring macrolide, as well as other 15- and
16-membered ringmacrolides (e.g., azithromycin, tilmicosin, and
tylosin), are of high efficacy against several important pathogens,
including Campylobacter, Chlamydia, andMycobacterium species
(20, 21). These antimicrobials inhibit bacterial protein synthesis
by binding to the 50S subunits of bacterial ribosome and have
been widely used for the treatment of infections in both humans
and animals for a number of years (20). The use of macrolides in
food-producing animals is considered to be one of the major fac-
tors influencing the emergence of Ery-resistant (Eryr) Campylo-
bacter (20). There are recent evidence indicating that the contin-
uous use of a macrolide at subtherapeutic level in chickens results
in the development of Ery resistance in Campylobacter (32, 34).
Although multiple mechanisms of macrolide resistance have
been reported in different bacterial genus and species, modifica-
tions of the ribosomal target sites (e.g., the 23S rRNA gene and
ribosomal proteins L4 and L22) and active efflux via the CmeABC
efflux pump are the major mechanisms conferring macrolide re-
sistance in Campylobacter (13, 19, 20, 41). To date, point muta-
tions in domain V of the 23S rRNA gene at positions 2074 and
2075, corresponding to positions 2058 and 2059 in Escherichia
coli, respectively, have been recognized as the most common
mechanism for macrolide resistance in C. jejuni and Campylobac-
ter coli (20, 41). Among the reported resistance-associated muta-
tions, the A2074C, A2074G, and A2075G mutations are found to
confer a high-level of macrolide resistance, while other mutations
in the 23S rRNA gene or the mutations in the ribosomal proteins
L4 (G74D) and L22 (insertions at position 86 or 98) are shown to
confer a lower level of macrolide resistance in Campylobacter (13,
14, 19, 20, 41).
In bacteria, the acquisition of antibiotic resistance, particularly
the resistance mediated by chromosomal mutations, is frequently
accompanied by a biological cost, resulting in a decrease in fitness
(i.e., a reduced growth rate or a decrease in ability to compete and
persist in the host and environment) of microorganisms in the
absence of antibiotic selection pressure (7–9, 30, 33, 40). Even
though many types of antibiotic resistance impose a biological
cost on bacterial fitness, the fitness cost can be reduced at different
levels through compensatory mutations (5, 10, 11, 33, 40). In ad-
dition, some resistance-conferring mutations or determinants do
not incur an apparent fitness burden or even enhance the fitness of
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the antibiotic resistant strains (10, 26, 31, 37, 38, 44). For example,
a modeling study on antibiotic resistance revealed that some re-
sistant bacteria, such as penicillin-resistant strains, did not show a
decreased fitness in the host; instead, these resistant strains pos-
sessed an increased ability to transmit between hosts compared to
the susceptible strains (6). In C. jejuni, it has been found that
fluoroquinolone (FQ)-resistant strains, carrying the C257T mu-
tation in the gyrA gene, do not show a fitness cost in its natural
host (chicken). Instead, the FQ-resistant mutants possess an en-
hanced fitness in the absence of antibiotic selection pressure (26).
Although macrolide resistance mechanisms were well defined
in Campylobacter, the impact of the resistance-associated muta-
tions on Campylobacter fitness has not been well defined. Re-
cently, it was shown that acquisition of Ery resistance imposes a
fitness burden inC. jejuni in culture medium as EryrCampylobac-
ter showed a competitive disadvantage compared to erythro-
mycin-susceptible (Erys) Campylobacter in mixed cultures (25,
27). However, the fitness changes observed in laboratory media
may not necessarily reflect the fitness alteration in vivo since the
environments in animals are much more complex than in culture
media (6, 11). More importantly, to facilitate the control of mac-
rolide resistance in Campylobacter, it is essential to assess whether
the resistance impacts Campylobacter fitness and transmissibility
in its natural hosts. Toward this end, we used clonally related and
isogenic mutants of Eryr Campylobacter to evaluate their fitness
and transmissibility in chickens, the major animal reservoir for C.
jejuni.
MATERIALS AND METHODS
Bacterial strains. C. jejuni strains used in the present study are listed in
Table 1. C. jejuni ATCC 700819 (NCTC 11168), Bd34-2, and Bd41-3 are
susceptible to Ery, whereas the other strains (J.L.270, J.L.272, J.L.273,
T.L.101, T.L.102, or T.L.103) exhibit low or high resistance to Ery (Table
1). The isolates Bd34-2, Bd41-3, J.L.270, J.L.272, and J.L.273 are clonally
related to ATCC 700819 and were isolated from chickens that were orig-
inally challenged with the parent strain ATCC 700819 and treated with
tylosin-containing feed as described in a previous study (34). Briefly, the
chickens were inoculated in laboratory with C. jejuni ATCC 700819 at 3
days of age and provided with the medicated feed (tylosin; 50 mg/kg of
feed) for the entire 41 days of the experiment. C. jejuniwas reisolated from
the inoculated chickens from cloacal swabs at different days after the
inoculation. Detailed information on the experiment is described in the
previous publication (34). The isogenic Eryr transformants T.L.101,
T.L.102, and T.L.103 were constructed from the parent strain ATCC
700819 using natural transformation (see below). These transformants
have either A2074G or A2075G mutation in the 23S rRNA gene and are
highly resistant to Ery (Table 1).
Construction of the Eryr transformants. To construct the isogenic
Eryr transformants, C. jejuni strains with the A2074G mutation (J.L.273)
or A2075G mutation (C.T.2–2) were used to prepare donor genomic
DNA for natural transformation. These Eryr Campylobacter strains were
originally isolated from chickens and turkeys (34, 36). Genomic DNA
from the Eryr strains was extracted using the Wizard Genomic DNA Pu-
rification Kit (Promega Corp., Madison, WI) according to the manufac-
turer’s protocol and then digested with the restriction enzyme EcoRV
prior to the natural transformation experiment. This digestion was done
to release the 23S rRNA gene from its flanking sequences in the donor
DNA, allowing the selection of transformants that only containmutations
in the 23S rRNA gene and minimizing the cotransfer of unrelated muta-
tions from the donor DNA to the transformants. Natural transformation
was performed with a biphasic method as described by Wang and Taylor
(45) using the parent strain ATCC 700819 as the recipient. Transformants
were selected on Mueller-Hinton (MH) agar containing 8 g of Ery/ml,
and the A2074G or A2075G mutation in the 23S rRNA gene of the iso-
genic Eryr transformants was confirmed by sequence analysis. 23S rRNA
gene-specific primers (5=-GTAAACGGCGGCCGTAACTA-3= and 5=-GA
CCGAACTGTCTCACGACG-3=) were used to amplify an internal part of
the domain V of the 23S rRNA gene (29). PCR amplification was per-
formed with an initial denaturation step at 94°C for 5min, followed by 35
cycles of 94°C for 30 s, 52°C for 30 s, and 72°C for 40 s, and a final
extension step at 72°C for 10 min. The amplified PCR products (714 bp)
were purified with the QIAquick PCR purification kit (Qiagen, Valencia,
TABLE 1 Characteristics of Campylobacter strains used in this study
Straina Description
Ery MIC
(g/ml)b
Mutation in
23S rRNAc
Erys strains
ATCC 700819 Highly motile variant of C. jejuni NCTC 11168 2 None
Bd34-2* Erys isolate from a chicken inoculated with 700819 and treated
with tylosin-containing feed
2 None
Bd41-3* Erys isolate from a chicken inoculated with 700819 and treated
with tylosin-containing feed
2 None
Clonally related Eryr strains
J.L.270* Eryr isolate from a chicken inoculated with 700819 and treated
with tylosin-containing feed
32 None
J.L.272* Eryr isolate from a chicken inoculated with 700819 and treated
with tylosin-containing feed
512 A2074G
J.L.273* Eryr isolate from a chicken inoculated with 700819 and treated
with tylosin-containing feed
512 A2074G
Isogenic Eryr strains
T.L.101† Laboratory-constructed Eryr transformant from 700819 512 A2074G
T.L.102† Laboratory-constructed Eryr transformant from 700819 512 A2075G
T.L.103† Laboratory-constructed Eryr transformant from 700819 512 A2075G
a *, Clonally related to 700819 and the dose of tylosin in the feed was 50 mg/kg of feed (34); †, transformants were from three independent transformation experiments.
b Determined by the agar dilution method.
c Corresponding to the nucleotide positions in the 23S rRNA gene of C. jejuni NCTC 11168.
Fitness Cost of Eryr Campylobacter
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CA) prior to sequencing. DNA sequencing was conducted at the DNA
facility of Iowa State University. Three transformants (T.L.101, T.L.102,
and T.L.103) derived from three independent transformation experi-
ments were used in the present study (Table 1).
Motility assay. Erys and Eryr Campylobacter strains were tested for
their motility prior to inoculation into chickens. Briefly, Erys and Eryr
Campylobacter strains grown overnight were resuspended in MH broth
and adjusted to an optical density at 600 nm of 0.3. Each Campylobacter
strain was inoculated to the center of semisolidMHmotility media (0.4%
MH agar) using a sterile needle. After incubation at 42°C for 48 h under
microaerobic conditions, the diameter of swarming from the inoculation
spot was measured in millimeters and recorded.
In vitro growth determination. To determine the in vitro growth of
the parent strain ATCC 700819, clonally related Eryr strains, and isogenic
Eryr transformants, a fresh culture of each Campylobacter strain was in-
oculated into MH broth and adjusted to an initial cell density of 105
CFU/ml. The cultures were incubated at 42°C with shaking (160 rpm) for
30 h undermicroaerobic conditions. The growth kinetics was determined
bymeasuring the numbers ofCampylobacter colonies (log10CFU/ml) at 0,
3, 6, 9, 12, 15, 18, 24, and 30 h postinoculation.
Pairwise competition experiments. Newly hatched broiler chickens
from a commercial hatchery were used to determine the in vivo competi-
tion between Eryr and Erys Campylobacter in the absence of antibiotic
selection pressure. The chickens used in the present study were tested
negative for Campylobacter by culturing cloacal swabs before use. These
birds were randomly assigned to groups with 10 to 15 birds per group.
Each group was inoculated with either a single or a mixture of Eryr and
Erys Campylobacter at 1:1 ratio via oral gavage. The Campylobacter strains
used for chicken inoculation were grown at 42°C for 24 h under mi-
croaerobic conditions. The inoculum was given to the birds at 3 days of
age with approximately 107 CFU per bird. Fecal samples were collected
from each bird by means of cloacal swabs at 3, 6, and 10 days postinocu-
lation (dpi). Each fecal samplewas serially diluted inMHbroth and plated
ontoMHagar containingCampylobacter selective agents and growth sup-
plements (SR084E and SR117E; Oxoid, Basingstoke, United Kingdom) to
recover the total Campylobacter colonies and onto MH agar containing
the same selective agents and growth supplements plus 8 g of Ery/ml to
recover Eryr Campylobacter colonies. Colony count was performed after
48 h of incubation at 42°C under microaerobic conditions. The results of
the differential plating were further confirmed by the MIC of selected
isolates by the agar dilution method.
Transmission of Eryr Campylobacter in chickens. Three groups of
newly hatched broiler chickens (11 to 13 birds per group) were used to
assess the transmissibility of Eryr Campylobacter between hosts. Each
group of chickens was inoculated with a single Campylobacter strain (107
CFU per bird) via oral gavage. The strains used in this experiment in-
cluded the Erys parent strain ATCC 700819, the isogenic Eryr transfor-
mants T.L.101 (carrying the A2074Gmutation) and T.L.102 (carrying the
A2075G mutation). At 5 dpi, when the colonization was established sim-
ilarly in each group by the corresponding strain, eight chickens inoculated
with the Erys strain and four chickens inoculated with the Eryr strain
T.L.101 were randomly selected and mingled together (2:1 ratio between
chickens inoculatedwith Erys andEryrCampylobacter, respectively). Like-
wise, 11 chickens inoculated with the Eryr strain T.L.102 were mingled
with 5 chickens originally inoculated with the Erys Campylobacter strain,
giving an approximately 1:2 ratio between chickens inoculated with Erys
and Eryr Campylobacter strains. The chickens (n 8) inoculated with the
EryrCampylobacter strain T.L.101 that were not used for comingling stud-
ies were raised separately and served as a control for determining the in
vivo stability of Eryr Campylobacter in the absence of antibiotic selection
pressure. Fecal samples were collected from each bird before comingling,
as well as at 7 and 14 days after comingling, using cloacal swabs. The
number of Erys and Eryr Campylobacter colonies was determined using
the differential platingmethod on bothMHagar andMHagar containing
8 g of Ery/ml as described earlier. The agar dilution method was also
performed to confirm the results of the differential plating.
Antimicrobial susceptibility test.TheMICs of Ery forCampylobacter
colonies randomly selected at each sampling time point were determined
using the agar dilution method as recommended by the CLSI (16). C.
jejuni 33560 was used as the quality control organism, and theMIC of Ery
at 8 g/ml was used as the resistance breakpoint in the present study. Ery
was obtained from Sigma Chemical Co., St. Louis, MO.
Statistical analysis. The significance of differences between Erys and
EryrCampylobacter in colonization levels at each sampling time point was
determined by using Student’s t test, Welch’s t test to allow for noncon-
stant variation across treatment groups, and the Wilcoxon rank-sum test
to allow for non-normality as described previously (24). Differences were
considered significant at a P value of0.05.
RESULTS
Characteristics of Eryr Campylobacter. The clonally related Eryr
strains (except J.L.270) and isogenic Eryr transformants carried
either A2074G or A2075G mutation in all three copies of the 23S
rRNA gene (Table 1). Although no specific point mutation was
observed in the 23S rRNA gene of J.L.270, this Eryr strain carried a
mutation in the ribosomal protein L4 (G74D). Since motility is a
key factor influencing the ability of Campylobacter to colonize the
chicken intestinal tract (18, 23, 28, 39), the motility of Eryr and
Erys Campylobacter strains used in the present study was investi-
gated. The Eryr and Erys strains were equally motile under the
laboratory conditions used here (data not shown). Compared to
the Erys strains, the Eryr isolates did not show apparent differences
in growth kinetics in MH broth except for J.L.270, which grew
slower than the rest of strains (Fig. 1). The Eryr strains harboring
either the A2074G or the A2075Gmutation in the 23S rRNA gene
were highly resistant to erythromycin (MICs 512g/ml), while
J.L.270, which carried the G74D point mutations in the L4 pro-
tein, had an EryMIC of 32g/ml (Table 1). All of the Erys isolates
had an Ery MIC of 2 g/ml (Table 1).
In vivo competition between clonally related isolates. To de-
terminewhether the acquisition ofmacrolide resistance affects the
fitness ofCampylobacter in its natural host, we conducted pairwise
competition experiments in chickens using clonally related strains
FIG 1 In vitro growth kinetics of clonally related and isogenicC. jejuni strains.
The cultures were incubated in MH broth at 42°C under microaerobic condi-
tions with shaking (160 rpm). Each data point represents the mean log10
CFU/ml of five technical replicates. The experiment was repeated twice and
similar results were obtained. 700819, Bd34-2, and Bd41-3 are Ery susceptible,
while J.L. 270, J.L.272, J.L.273, and T.L.102 are Ery resistant (see Table 1 for
MIC values).
Luangtongkum et al.
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of C. jejuni. When the Erys C. jejuni ATCC 700819 strain and its
clonally related Eryr strains were individually inoculated into
chickens, both Erys and Eryr strains were able to colonize the
chicken intestinal tract effectively at similar levels (Fig. 2). How-
ever, when these Erys and EryrCampylobacterwere concomitantly
inoculated into chickens, Erys strain outcompeted Eryr strains as
early as dpi 3 (Fig. 3A, B, and C). For example, when ErysC. jejuni
ATCC 700819 and Eryr strain J.L.270 were coinoculated into
chickens, only C. jejuni ATCC 700819 was detected in the chicken
intestinal tract throughout the 10-day study period (Fig. 3A). Sim-
ilarly, when Erys C. jejuni ATCC 700819 and Eryr strain J.L.272
were coinoculated into chickens, the majority of the birds were
colonized only by the Erys strain, and the Eryr Campylobacter was
clearly outcompeted by the Erys strains (Fig. 3B). Although Eryr
strain J.L.273 was detected in the majority of the chickens after
coinoculated with Erys Campylobacter, it was outnumbered by
700819 and was cleared from 7 of the 11 inoculated chickens (Fig.
3C). These results indicate that Eryr C. jejuni is less fit than Erys C.
jejuni in chickens in the absence of antibiotic selection pressure.
To confirm the fitness burden observed in Eryr C. jejuni, two
additional pairwise competition experiments using clonally re-
lated Erys and Eryr C. jejuni derived from experimentally chal-
lenged chickens (Bd34-2 versus J.L.272 and Bd41-3 versus
J.L.273) were conducted. Remarkably, similar results were ob-
served in both pairwise competition experiments, in which EryrC.
jejuni was outcompeted by Erys C. jejuni as early as dpi 3, and no
Eryr C. jejuni was detected in feces collected at dpi 10 from both
pairwise competition groups (Fig. 3D and E). The predominance
of Erys Campylobacter in the coinoculated chickens was further
confirmed by MIC testing of randomly selected Campylobacter
colonies. The agar dilution test showed that 95.30% (162 of 170)
of the tested Campylobacter colonies were susceptible to Ery (Ta-
ble 2), confirming the results of the differential plating. Together,
these findings demonstrated that Erys C. jejuni is more fit than
clonally related Eryr C. jejuni in chickens in the absence of antibi-
otic selection pressure.
In vivo competition between isogenic isolates. To determine
whether the fitness cost observedwith EryrC. jejuniwas associated
with the specific resistance-conferringmutations in the 23S rRNA
gene, isogenic Eryr transformants were generated from the Erys
parent strain C. jejuni ATCC 700819 and used for pairwise com-
petition experiments. When the Erys parent strain and the iso-
genic Eryr transformant carrying the A2074Gmutation in the 23S
rRNA gene (T.L.101) were concomitantly inoculated into chick-
ens, the Erys strain quickly outcompeted T.L.101 (Fig. 3F). Al-
though C. jejuni T.L.101 was isolated from four chickens at dpi 3,
none of the samples collected at dpi 6 and only 1 of 10 samples
from dpi 10 were positive for this Eryr Campylobacter strain (Fig.
3F). Likewise, when Eryr transformants carrying the A2075Gmu-
tation in the 23S rRNA gene (T.L.102 and T.L.103) and the iso-
genic Erys parent strain ATCC 700819 were coinoculated into
chickens, the isogenic Eryr transformants were outcompeted by
the Erys parent strain as early as dpi 3 (Fig. 3G and H). Similar to
the clonally relatedC. jejuni strains, theMIC results from the agar
dilutionmethod also confirmed the results of the differential plat-
ing. All of the 55 testedCampylobacter colonies were susceptible to
Ery (Table 2). Together, these findings strongly suggest that the
fitness cost observed in Eryr C. jejuni is linked to the specific point
mutations in the 23S rRNA gene.
Transmission of Eryr Campylobacter in chickens. To assess
the ability of EryrCampylobacter to transmit between chickens, we
conducted a comingling experiment using three groups of chick-
ens that were precolonized with the Erys parent strain ATCC
700819, the isogenic Eryr transformant T.L.101, or the isogenic
Eryr transformant T.L.102. Before comingling, the chickens inoc-
ulated with ATCC 700819, T.L.101, or T.L.102 were colonized at
similar levels (data not shown).When chickens precolonized with
ATCC 700819 (Erys) were mingled with chickens precolonized
with T.L.101 (Eryr), no Eryr Campylobacter was detected in the
feces of Erys inoculated chickens throughout the study period
(Fig. 4A). In contrast, ErysCampylobacterwas detected from feces
of chickens precolonized with the Eryr strain at both 7 and 14 days
after comingling (Fig. 4B). Moreover, Erys C. jejuni totally dis-
placed EryrCampylobacter in 2 of the 4 Eryr precolonized chickens
at 14 days after comingling. Similar results were also observed
when chickens precolonized with the Erys parent strain ATCC
700819 were mingled with chickens precolonized with the iso-
genic Eryr transformant T.L.102. Among 5 chickens originally col-
FIG2 Colonization levels of ErysC. jejuniATCC700819 () and clonally related Eryr strains J.L.272 () and J.L.273 (o) in chickens. EachCampylobacter strain
was individually inoculated into chickens at the concentration of 1.4 106 CFU/bird (ATCC 700819), 5.56 105 CFU/bird (J.L.272), and 2.57 105 CFU/bird
(J.L.273). Fecal samples were collected at 3, 6, and 10 days after inoculation. Each data point represents the number ofCampylobacter obtained from an individual
chicken. The mean colonization level (log10 CFU/g feces) of each group is indicated by a horizontal bar.
Fitness Cost of Eryr Campylobacter
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onized with ErysCampylobacter, all but one were negative for Eryr
Campylobacter at both 7 and 14 days after comingling (Fig. 4C). In
contrast, 10 of 11 chickens originally colonized with Eryr Campy-
lobacterwere positive for Erys strain at 7 days after comingling. At
14 days after comingling, seven of the 11 chickens precolonized by
Eryr Campylobacter were completely replaced by the Erys strain
(Fig. 4D). Notably, the number of Eryr Campylobacter in the feces
of chickens precolonizedwith the Eryr strainT.L.102 reduced con-
siderably, whereas the number of Erys Campylobacter rapidly in-
creased after comingling. Together, these results indicate that Eryr
Campylobacter is highly impaired in its transmission to chickens
with an established Erys Campylobacter population and that it can
be readily displaced by sensitive Campylobacter in the absence of
antibiotic selection pressure.
FIG 3 Pairwise competition between Erys and Eryr Campylobacter in chickens in the absence of antibiotic selection pressure. (A to E) Competition between
clonally related isolates. (A) ATCC 700819 () versus J.L.270 (Œ); (B) ATCC 700819 () versus J.L.272 (); (C) ATCC 700819 () versus J.L.273 (o); (D)
Bd34-2 () versus J.L.272 (); (E) Bd41-3 (Œ) versus J.L.273 (o). (F toH)Competition between isogenic strains. (F) ATCC 700819 () versus T.L.101 (N); (G)
ATCC 700819 () versus T.L.102 (n); (H) ATCC 700819 () versus T.L.103 (‡). Each symbol represents the number of Erys or Eryr Campylobacter in an
individual chicken. The horizontal bars represent the mean colonization levels (log10 CFU/g feces) of Erys or Eryr strains detected at each sampling time point.
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To confirm the transmission of ErysCampylobacter to Eryr col-
onized chickens, MIC testing was performed with randomly se-
lected Campylobacter colonies isolated from the comingled chick-
ens. Among Campylobacter colonies collected at 7 and 14 days
postmingling, 62.5 and 40.0% of the colonies from chickens orig-
inally colonized with T.L.101 and T.L.102, respectively, were sus-
ceptible to Ery (Table 3). In contrast, none of the isolates from the
chickens precolonized with Erys Campylobacter were resistant to
Ery (Table 3). TheseMIC data further confirmed the transmission
of Erys Campylobacter to chickens precolonized by Eryr Campylo-
bacter and the inability of Eryr Campylobacter to spread to chick-
ens with an established Erys Campylobacter population.
Chickens inoculated with the Eryr strain T.L.101 that were not
mingled with Erys inoculated chickens were used as a control to
assess the phenotypic stability of Eryr Campylobacter in chickens
in the absence of antibiotic selection pressure. T.L.101 coloniza-
tion in the inoculated chickens persisted for the entire experimen-
tal period (Fig. 4E). The EryMICs for the randomly selectedCam-
pylobacter colonies were also 512 g/ml (Table 3), indicating
that T.L.101 stably maintained the Eryr phenotype in the absence
of antibiotic selection pressure. This result suggests that the ap-
pearance of Erys Campylobacter in chickens precolonized with
Eryr Campylobacter was not due to the reversion of the resistance
phenotype.
DISCUSSION
In this study, we examined the ecological fitness of Eryr Campylo-
bacter in chickens in the absence of antibiotic selection pressure by
using clonally related and isogenic strains of C. jejuni. The results
clearly indicate that acquisition of macrolide resistance entails a
fitness cost for C. jejuni in its natural host. From the pairwise
competition experiments, it was clear that EryrCampylobacterwas
outcompeted rapidly by Erys strains (Fig. 3). In addition, when
chickens colonized with Eryr C. jejuni were comingled with birds
colonized with Erys C. jejuni, Erys Campylobacter was able to
transmit to and colonize in the chickens precolonized by Eryr
Campylobacter, while EryrC. jejuni failed to transmit to the chick-
ens precolonized by Erys Campylobacter (Fig. 4). Together, these
findings reveal the fitness burden of EryrCampylobacter in its nat-
ural host in the absence of antibiotic selection pressure.
The use of clonally related and isogenic transformants in the
chicken experiments linked the fitness burden to the point muta-
tions in the 23S rRNA gene of Eryrmutants. However, it should be
pointed out that natural transformation may not necessarily gen-
erate true isogenicmutants since other unrelatedmutationsmight
be also transferred to the transformants. To minimize this poten-
tial problem, we digested the donor DNA with EcoRV prior to
transformation to release the 23S rRNA gene from the rest of the
genome. In addition, we used three transformants from three in-
dependent transformations for the chicken experiments, all of
which yielded the same results (Fig. 3 and Fig. 4). Furthermore,
the clonally related isolates also consistently showed a significant
fitness cost in the Eryr mutants. Collectively, these findings pro-
vide strong evidence that links the resistance-conferringmutation
in the 23S rRNA to the reduced fitness in chickens.
It has been shown that certainmutations in the 23S rRNAgene,
such as the A2074G transition, may have a negative effect on the
growth rate ofCampylobacter in culture media (19, 25). However,
in the present study we found that the growth rates of the Eryr
mutants carrying the A2074G or A2075G mutations were similar
to that of the Erys wild-type strain (Fig. 1). Similar to our finding,
other studies (27, 34) also reported that the Eryr mutants with the
A2074G transition or A2074C transversion did not show any
growth defect compared to Erys parent strains. Thus, the fitness
cost for the Eryr mutants carrying mutations in the 23S rRNA
genes is not attributable to a growth defect. In addition, the Eryr
mutants colonized at levels similar to the Erys strain when mono-
inoculated into chickens (Fig. 2) but colonized at levels signifi-
cantly lower than the Erys strains when coinoculated into chickens
(Fig. 3). These results indicate that the fitness cost was primarily
due to the inability of Eryr mutants to compete with ErysC. jejuni.
J.L.270, which carried amutation in the L4 protein (Table 1), grew
slower than other strains (Fig. 1), and its resistance phenotype was
not stable when assessed by passage in laboratory media (not
shown). Thus, the fitness cost of this strain could be explained
partly by the growth defect and the instability of its resistance
TABLE 2MICs of randomly selected C. jejuni colonies from the competition experiments
Pairwise
competition
No. of isolates with an Ery MIC
(g/ml)a of:
No. of Erys and Eryr isolatesb at:
Total no. of isolates (%)dpi 3 dpi 6 dpi 10
0.25 0.5 1 2 4 Erys Eryr Erys Eryr Erys Eryr Erys Eryr
Clonally related pairs
700819/J.L.270 0 1 23 9 0 11 0 11 0 11 0 33 (100.0) 0 (0)
700819/J.L.272 0 0 15 7 4* 7 2 8 1 7 1 22 (84.6) 4 (15.4)
700819/J.L.273 0 1 20 8 4* 9 2 10 1 10 1 29 (87.9) 4 (12.1)
Bd34-2/J.L.272 5 6 0 26 0 11 0 12 0 14 0 37 (100.0) 0 (0)
Bd41-3/J.L.273 0 12 0 29 0 12 0 15 0 14 0 41 (100.0) 0 (0)
Total 5 20 58 79 8 50 4 56 2 56 2 162 (95.3) 8 (4.7)
Isogenic pairs
700819/T.L.101 0 0 1 21 0 7 0 7 0 8 0 22 (100.0) 0 (0)
700819/T.L.102 0 0 3 14 0 0 0 8 0 9 0 17 (100.0) 0 (0)
700819/T.L.103 2 0 7 7 0 3 0 7 0 6 0 16 (100.0) 0 (0)
Total 2 0 11 42 0 10 0 22 0 23 0 55 (100.0) 0 (0)
a *, The actual MICs of these isolates were512 g/ml.
b The isolates were randomly selected from plating at 3, 6, and 10 days postinoculation (dpi). The breakpoint for Ery resistance is8 g/ml.
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phenotype. In contrast to J.L. 270, other tested Eryrmutants stably
maintained Ery resistance in both laboratory media (data not
shown) and in chickens (Fig. 2 and Fig. 4E).
The fitness cost of Eryr C. jejuni in its natural hosts revealed in
the present study is consistent with results obtained with other
model systems. Two studies using in vitro culture systems demon-
strated that Eryr C. jejuni was less fit than Erys Campylobacter in
mixed cultures (25, 27). In addition, another study showed a fit-
ness cost of macrolide-resistant Campylobacter carrying an
A2074C mutation in the colonization of mice (3). These studies
using different systems consistently demonstrated the fitness cost
of macrolide-resistant Campylobacter. The association between
macrolide resistance and a significant burden on bacterial fitness
was also observed in other bacteria. When a sequential passage of
a mixed culture between macrolide-resistant and macrolide-
susceptible Helicobacter pylori was performed, the ratio of the re-
sistant strain to the susceptible strain was considerably reduced
per passage (31). It was also shown that clarithromycin resistance
confers a fitness cost on H. pylori in mice and the fitness cost was
reduced in clinical isolates (9). A recent study demonstrated that
azithromycin resistance mutations reduced the virulence and fit-
ness of Chlamydia caviae in guinea pigs (8). The reason for the
reduced fitness of macrolide-resistant bacteria is unknown at
present, but it is plausible to speculate that the resistance-
conferringmutations in bacteria 23S rRNA genemight affect pro-
tein synthesis rates. Since macrolide antibiotics are known to in-
hibit protein synthesis and ribosomal assembly in bacteria (15),
mutations that counteract the inhibitory effects of macrolides
might alter protein synthesis, leading to a fitness disadvantage in
the absence of antibiotic selection.
FIG 4 Levels ofCampylobacter colonization in chickens before and after comingling. (A) Colonization levels ofCampylobacter in chickens (n 8) precolonized
with Erys C. jejuni ATCC 700819 before and after comingling with chickens (n 4) precolonized with Eryr transformant T.L.101. The numbers of 700819 and
T.L.101 in the chickens are indicated by solid circles () and open triangles (o), respectively. (B) Colonization levels of Campylobacter in chickens (n  4)
precolonized with Eryr transformant T.L.101 before and after comingling with chickens (n 8) precolonized with Erys C. jejuni ATCC 700819. The numbers of
700819 andT.L.101 in the chickens are indicated by by solid circles () and open triangles (o), respectively. (C)Colonization levels ofCampylobacter in chickens
(n 5) precolonized with Erys C. jejuni ATCC 700819 before and after comingling with chickens (n 11) precolonized with Eryr transformant T.L.102. The
numbers of 700819 andT.L.102 in the chickens are indicated by solid circles () and open diamonds (), respectively. (D) Colonization levels ofCampylobacter
in chickens (n  11) precolonized with Eryr transformant T.L.102 before and after comingling with chickens (n  5) precolonized with Erys C. jejuni ATCC
700819. The numbers of 700819 and T.L.102 in the chickens are indicated by solid circles () and open diamonds (), respectively. (E) Colonization levels of
Eryr strain T.L.101 in chickens (n 8) in the absence of competing Erys C. jejuni. These non-mingled chickens were used as a control for the comingling study.
In panels A to E, each data point represents the log10 transformed CFU number/g of feces from a single bird, and the mean colonization level (log10 CFU/g of
feces) is indicated by a horizontal bar.
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The comingling experiments revealed an impaired transmis-
sion of Eryr Campylobacter to chickens precolonized by Erys C.
jejuni (Fig. 4). In contrast, ErysC. jejuniwas able to transmit to and
establish colonization in chickens that were precolonized by Eryr
C. jejuni. In some birds, the Eryr strains were totally replaced by
Erys strains after comingling. This finding implies that in the nat-
ural reservoir (chickens), where Campylobacter is prevalent, it is
likely that Eryr Campylobacter encounters a difficulty in spread
among birds in the absence of antibiotic selection. It should be
pointed out that the Erys Campylobacter isolated from the chick-
ens previously colonized with a Eryr strain was unlikely the result
of the reversion or loss of the A2074G or A2075Gmutations in the
23S rRNA gene since these mutations are stable as shown in the
chickens colonizedwith the EryrCampylobacter only (Fig. 4E) and
in other published work (14, 19, 27). The finding from the com-
ingling experiments confirms and complements the results of
pairwise competition experiments and indicates that EryrCampy-
lobacter is less fit than Erys Campylobacter in its natural host.
Our laboratory findings reported here are consistent with the
national surveillance data in the United States and Denmark. In
the United States, the use of macrolide antimicrobials in animal
production has been a practice for years, but the prevalence of Eryr
C. jejuni has been at a low level (22). In Denmark, reduced use of
tylosin as a growth promoter in swine led to a significant decrease
in the number of Eryr C. coli isolated from pigs (1). Based on our
laboratory observations using clonally related isolates derived
from chickens and the transmission studies (Fig. 2, 3, and 4), we
expect that a similar situation (i.e., outcompetition of Eryr C. je-
juni by Erys strains) occurs on chicken farms. However, the labo-
ratory findings should be extrapolated to on-farm settings cau-
tiously sincemany factors influence bacterial fitness. For example,
the use of macrolide antimicrobials on farms would provide a
selective advantage for Eryr Campylobacter and facilitates the
maintenance of the resistant population. In addition, compensa-
tory mutations could occur under prolonged selection, which
might reduce the fitness cost associated with Ery resistance. Fur-
thermore, the ecological fitness of C. jejuni can be influenced by
other bacterial and environmental factors. Thus, the fitness pic-
ture of C. jejuni in animal reservoirs is more complex than that
revealed in a laboratory setting and is likely influenced by interac-
tions of many different factors.
The reduced fitness of EryrCampylobacter is a stark contrast to
fluoroquinolone (FQ)-resistantCampylobacter, which can rapidly
outcompete FQ-susceptible strains and can be persistently main-
tained in chickens in the absence of antibiotic selection pressure
(37). This difference indicates that different antimicrobial resis-
tance mechanisms have varied effects on the fitness of Campylo-
bacter in animal reservoir. The fitness burden of EryrCampylobac-
ter in antibiotic-free environments, the low spontaneous
mutation rate for macrolide resistance (34), and the slow process
of macrolide resistance development (32, 34) may have all con-
tributed to the relatively low prevalence of resistance tomacrolide
antimicrobials compared to FQ resistance in C. jejuni. Although
withdrawal of FQ antimicrobials in the United States has thus far
had a limited effect on the prevalence of FQ-resistant Campylo-
bacter in poultry (35, 42, 43),management ofmacrolide antibiotic
usage on farms is likely to be an effective way to reduce the prev-
alence of macrolide resistance in Campylobacter.
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